ArticleMedicine2025
Identification and analysis of a novel A allele with a c.565A > G variant on the ABO*A1.02 allele leading to subtype A: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
rationaleThe ABO blood group system typically includes 4 phenotypes: type A, type B, type O, and type AB. ABO subtypes refer to further subdivisions within these 4 blood types. We report a case of subtype A, focusing on elucidating the molecular mechanisms of this rare genotype. PATIENT CONCERNS: The patient is a 34-year-old pregnant woman at 39 weeks gestation presenting with preterm labor. She exhibits forward and reversed stereotypic incompatibility. DIAGNOSES: All exons of ABO were amplified by PCR and sequenced using Sanger sequencing. Furthermore, only the seventh exon was sequenced by TA cloning for haplotype analysis. Sequencing analysis revealed that the genotypes ABO*A1.02 and ABO*O.01.02, and the mutation c.565A > G, which has never been reported for the A allele, occurred based on ABO*A1.02.
interventionsIn addition to serological test, the patient underwent further molecular biology test. OUTCOMES: It led to identify a novel allele with subtype A serological characteristics, caused by the c.565A > G variant, which leads to a weakened A antigen. LESSONS: Given its rarity, it is advisable to employ dual serological and molecular biological testing mechanisms during complex ABO blood typing to prevent missed detection and misclassifications, thereby effectively promoting transfusion and compatibility safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.